Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The 'Artemis Technologies' name refers to two distinct life science entities that were later acquired. The Canadian entity, Artemis Technologies Inc., developed and commercialized the ONRAB® oral rabies vaccine for wildlife control. It was acquired by Ceva Santé Animale in 2022. The German entity, Artemis Pharmaceuticals, was a leading provider of custom genetically engineered rodent models for drug discovery, acquired first by Exelixis and later by Taconic Farms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artemis Technologies.